Saturday, November 21, 2015
Print Current Session:
|
|
Saturday
SESSION 103:
MORE EXCITING NEW DEVELOPMENTS IN LOWER EXTREMITY DISEASE AND ITS TREATMENT (4 1/2-Minute Hit The Highlights Talks)
Moderators:Iris Baumgartner, MD / Kenneth Ouriel, MD, MBA
|
|
SESSION 103 SCHEDULE | |
8:05 AM - 8:10 AM | Special Considerations In Treating CLI In ESRD-Dialysis Patients Endovascularly |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Objective Performance Goals For Lower Extremity CLI Bypasses With And Without ESRD |
Presenter(s):Mark Conrad, MD, MMSc | |
View Slides in PDF | |
8:15 AM - 8:20 AM | With Severe CLI (Rutherford 5 And 6) Patient Survival After Endo Treatment Is Poor And Better With Open Surgery Treatment |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
8:20 AM - 8:25 AM | The Positive Correlation Between Osteoporosis And Arterial Disease: What Is Its Significance |
Presenter(s):Caron B. Rockman, MD | |
View Slides in PDF | |
8:25 AM - 8:30 AM | Micro-Oxygen Sensors (MOXYs) On Feet To Monitor The Effectiveness In Real Time Of Endovascular Treatments In CLI Patients |
Presenter(s):Miguel F. Montero-Baker, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | DEBATE: How To Deal With Occluded Fempop Grafts Endovascularly: No Open Treatment Is Ever Needed |
Presenter(s):Marcelo Guimaraes, MD, FSIR | |
View Slides in PDF | |
8:35 AM - 8:40 AM | DEBATE: Not So: There Is A Hybrid (Open/Endo) Technique Which Works Well When Endo Treatments Fail: Technique And Results |
Presenter(s):Neal S. Cayne, MD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | Panel Discussion |
Moderator(s): Caron B. Rockman, MD / Daniel G. Clair, MD | |
8:45 AM - 8:50 AM | Treating Dissection, Perforations, Embolization And Other Complications Of Lower Extremity Interventions When Endo Rescue Fails: Tips And Tricks |
Presenter(s):Scott L. Stevens, MD | |
View Slides in PDF | |
8:50 AM - 8:55 AM | DEBATE: Statins After Infrainguinal Treatments For CLI Improves Patient Survival But With No Improved Patency |
Presenter(s):Philip P. Goodney, MD, MS | |
View Slides in PDF | |
8:55 AM - 9:00 AM | DEBATE: Statins After Infrainguinal Treatments For CLI Improves Patency As Well As Patient Survival |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
9:00 AM - 9:05 AM | 2-Year Results With The Stellarex DEB Without Pre-Dilatation Show Durable Results With TASC A And B Lesions: The ILLUMENATE FIH Trial |
Presenter(s):Koen Deloose, MD / Marianne Brodmann, MD | |
View Slides in PDF | |
9:05 AM - 9:10 AM | Not All ISR Lesions Need To Be Treated And Duplex Surveillance Predict ISR Lesions Requiring Treatment: Lesions >80% Require Treatment; Those <80% Can Be Observed |
Presenter(s):Miguel F. Montero-Baker, MD | |
View Slides in PDF | |
9:10 AM - 9:15 AM | Pathologic Insight Into The Safety And Efficacy Of Various Endovascular Treatments For ISR And CLI |
Presenter(s):Renu Virmani, MD | |
View Slides in PDF | |
9:15 AM - 9:20 AM | Durable Value Of DESs In Tibial Arteries For CLI: 3-4 Year Results: Indications And Contraindications |
Presenter(s):Michael J. Wilderman, MD | |
View Slides in PDF | |
9:20 AM - 9:30 AM | Panel Discussion And Break Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 103 | |
previous | next |